TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -3 | -2 | 11 | 7 | -1 | -25 | -2 |
| P | %wins | 0 | 0 | 100 | 100 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/16 13:15 | 5/20/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mattingly Martin A | WA | D | M.d | 0 | 0.00 | 1 | 3 | 31 | 11 | D | -76 | -51 | -61 | 48 | 20 | -12 | 8 | -10 | 8 | 11 | 14 | -36 | -46 | ||
5/22/15 09:35 | 5/20/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mattingly Martin A | WA | D | M.d | 0 | 0.00 | 0 | 3 | 45 | 8 | D | -82 | -49 | -12 | -17 | -21 | -4 | 6 | 1 | -2 | 12 | 48 | 32 | 23 | -53 | |
6/9/14 12:24 | 6/5/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mattingly Martin A | WA | D | M.d | 0 | 0.00 | 1 | 3 | 83 | 6 | D | -72 | -65 | -56 | -72 | -64 | -9 | -15 | 3 | 1 | -5 | -3 | -11 | -35 | -25 | |
5/28/13 12:31 | 5/23/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mattingly Martin A | WA | D | M.d | 21 | 10.64 | 1 | 2 | 200 | 3 | D | -32 | -17 | -10 | -10 | 3 | 3 | 6 | 3 | -1 | -4 | -12 | -14 | -25 | -64 | |
6/4/12 12:39 | 6/1/12 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mattingly Martin A | WA | D | P.d | 12 | 12.46 | 1 | 1 | New | 1 | D | -10 | -29 | 9 | -18 | 8 | 0 | 0 | -1 | -3 | -2 | 11 | 7 | -1 | -25 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |